BODY ACTION PRODUCTS Climax Control Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: BODY ACTION PRODUCTS Climax Control Gel
Generic name: BENZOCAINE
Manufacturer: PRODUCT MAX GROUP INC
Product type: HUMAN OTC DRUG
SPL set ID: 53e746cc-0078-4381-bf0b-9c8f98d66904
SPL ID: 09d7805e-6565-5fa8-e063-6294a90ac4bb
Version: 2
Effective date: 2023-11-10
Source export date: 2026-10-27
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/2c7d3f7bcea1543046130e07dcbaf7eea5fb0ce23f7faa6458d1c6d80c3fa0c3/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:43:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		BODY ACTION PRODUCTS Climax Control Gel	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		PRODUCT MAX GROUP INC	openfda.manufacturer_name
ndc	package	70742-282-00	openfda.package_ndc
ndc	product	70742-282	openfda.product_ndc
ndc11	package	70742028200	derived:openfda.package_ndc
spl id		09d7805e-6565-5fa8-e063-6294a90ac4bb	id
spl set id		53e746cc-0078-4381-bf0b-9c8f98d66904	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with the eyes. Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor. If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.